4//SEC Filing
Lin Kenneth 4
Accession 0001209191-22-052187
CIK 0001815974other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:11 PM ET
Size
5.3 KB
Accession
0001209191-22-052187
Insider Transaction Report
Form 4
Lin Kenneth
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-21+30,425→ 30,425 totalExercise: $6.00Exp: 2027-02-28→ Common Stock (30,425 underlying)
Footnotes (1)
- [F1]25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001770623
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:11 PM ET
- Size
- 5.3 KB